Table 1. Categorization of Reports about Control of MDROs in Healthcare Settings, 1982-2005
Management of Multidrug-Resistant Organisms in Healthcare Settings (2006)
MDRO | MDR-GNB | MRSA | VRE |
---|---|---|---|
No. of Studies Reviewed/category | 30 | 35 | 39 |
Facility Type | MDR-GNB | MRSA | VRE |
---|---|---|---|
No. (%) from academic facilities α | 30 (100) | 28 (80) | 33 (85) |
No. (%) from other hospitals | 0 | 4 (11) | 3 (8) |
No. (%) from LTCFs | 0 | 1 (3) | 2 (5) |
No. (%) from multiple facilities in a region | 0 | 2 (6) | 1 (2) |
α Variably described as university hospitals, medical school affiliated hospitals, VA teaching hospitals, and, to a much lesser extent, community teaching hospitals
Unit of Study | MDR-GNB | MRSA | VRE |
---|---|---|---|
Special unit β | 20 | 13 | 19 |
Hospital | 10 | 19 | 17 |
LTCF | 0 | 1 | 2 |
Region | 0 | 2 | 1 |
β Includes intensive care units, burn units, dialysis units, hematology/oncology units, neonatal units, neonatal intensive care units, and, in a few instances, individual wards of a hospital
Nature of Study | MDR-GNB | MRSA | VRE |
---|---|---|---|
Outbreak | 22 | 19 | 28 |
Non-outbreak | 8 | 16 | 11 |
χ Based on authors’ description – if they called their experience an outbreak or not; authors vary in use of term so there is probable overlap between two categories
Time Period | MDR-GNB | MRSA | VRE |
---|---|---|---|
Less than 1 year | 17 | 14 | 25 |
1-2 years | 6 | 6 | 6 |
2-5 years | 5 | 11 | 8 |
Greater than 5 years | 2 | 4 |
Outbreak Control Measures | MDR-GNB | MRSA | VRE |
---|---|---|---|
Range | 2-12 | 0-11 | 1-12 |
Median | 7 | 7 | 8 |
Mode | 8 | 7 | 9 |